Distal protection devices in primary percutaneous coronary intervention of native coronary artery lesions: A meta-analysis of randomized controlled trials

Current Medical Research and Opinion

Volumn 28, Issue 6, 2012, Pages 871-876

  Jin, Bo ^a   Dong, Xue Hong ^b   Zhang, Chao ^a   Li, Yong ^a   Shi, Hai Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Distal protection; Meta analysis; Myocardial infarction; Percutaneous coronary intervention; Randomized controlled trials

Indexed keywords

ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DATA BASE; DISTAL PROTECTION DEVICE; EMBASE; EMBOLIC PROTECTION DEVICE; GUIDE WIRE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; CORONARY ARTERY DISEASE; EMBOLIC PROTECTION DEVICES; ENDOVASCULAR PROCEDURES; GUIDELINE ADHERENCE; HUMANS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84862580463     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.686445     Document Type: Article

References (28)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20
2. Mehta RH, Granger CB, Alexander KP, et al. Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks. J Am Coll Cardiol 2005;45:471-8
3. Henriques JP, Zijlstra F, Ottervanger JP, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002;23:1112-17
4. Haeck JD, Verouden NJ, Henriques JP, et al. Current status of distal embo-lization in percutaneous coronary intervention: mechanical and pharmacological strategies. Future Cardiol 2009;5:385-402
5. Stone GW, Peterson MA, Lansky AJ, et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39:591-7
6. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47
7. Mauri L, Rogers C, Baim DS. Devices for distal protection during percutaneous coronary revascularization. Circulation 2006;113:2651-6
8. Roffi M, Mukherjee D. Current role of embolic protection devices in percutaneous coronary and vascular interventions. Am Heart J 2009;157:263-70
9. Cura FA, Escudero AG, Berrocal D, et al. PREMIAR Investigators. Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). Am J Cardiol 2007;99:357-63
10. Duan YY, Zhang HB, Liu LW, et al. Effects of distal protection on left ventricular function in acute anterior myocardial infarction: a Doppler echocardiographic study. Int J Cardiovasc Imaging 2010;26:125-33
11. Feng XY, Liu HT, Gao Y, et al. Efficiency and safety of percuSurge distal protection device in acute myocardial infarction during emergent percutaneous coronary intervention treatment. Afr J Biotechnol 2011;10:3444-50
12. Gick M, Jander N, Bestehorn HP, et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005;112:1462-9
13. Guetta V, Mosseri M, Shechter M, et al. UpFlow MI Study Investigators. Safety and efficacy of the FilterWire EZ in acute ST-segment elevation myocardial infarction. Am J Cardiol 2007;99:911-15
14. Hahn JY, Gwon HC, Choe YH, et al. Effects of balloon-based distal protection during primary percutaneous coronary intervention on early and late infarct size and left ventricular remodeling: a pilot study using serial contrast-enhanced magnetic resonance imaging. Am Heart J 2007; 153:665.e1-8
15. Ito N, Nanto S, Doi Y, et al. Distal protection during primary coronary intervention can preserve the index of microcirculatory resistance in patients with acute anterior ST-segment elevation myocardial infarction. Circ J 2011; 75:94-8
16. Kelbaek H, Terkelsen CJ, Helqvist S, et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol 2008;51:899-905
17. Matsuo A, Inoue N, Suzuki K, et al. Limitations of using a GuardWire temporary occlusion and aspiration system in patients with acute myocardial infarction: multicenter investigation of coronary artery protection with a distal occlusion device in acute myocardial infarction (MICADO). J Invasive Cardiol 2007;19:132-8
18. Muramatsu T, Kozuma K, Tsukahara R, et al. ASPARAGUS Trial Investigators. Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: angiographic and clinical results of a randomized controlled trial. Catheter Cardiovasc Interv 2007; 70:677-82
19. Ochała A, Smolka G, Wojakowski W, et al. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty. Kardiol Pol 2007;65:672-80
20. Ozaki Y, Nomura M, Nakayama T, et al. Effects of thrombus suction therapy on myocardial blood flow disorders in males with acute inferior myocardial infarction. J Med Invest 2006;53:167-73
21. Stone GW, Webb J, Cox DA, et al. Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators. Distal microcircu-latory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005;293:1063-72
22. Tahk SJ, Choi BJ, Choi SY, et al. Distal protection device protects microvas-cular integrity during primary percutaneous intervention in acute myocardial infarction: a prospective, randomized, multicenter trial. Int J Cardiol 2008;123:162-8
23. Zhou BQ, Tahk SJ. Effect of a distal protection device on epicardial blood flow and myocardial perfusion in primary percutaneous coronary intervention. J Zhejiang Univ Sci B 2007;8:575-9
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
25. Srinivasan M, Rihal C, Holmes DR, et al. Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on micro-vascular perfusion and outcomes. Circulation 2009;119:1311-19
26. Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 2001;22:729-39
27. Bolognese L, Carrabba N, Parodi G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004; 109:1121-6
28. Kaltoft A, Kelbaek H, Kløvgaard L, et al. Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2010;55:867-71